Back to Newsroom

New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax’ Vaccine Against H7N9 Avian Flu

ROCKVILLE, Md., Nov. 13, 2013 (GLOBE NEWSWIRE) — Novavax, Inc. (NVAX) today announced that positive clinical data for the company’s virus-like particle (VLP) vaccine candidate against A(H7N9) influenza were published online in the Correspondence section of The New England Journal of Medicine. The correspondence can be found at: and will appear in the December 26, 2013 print edition.